InvestorsHub Logo
Followers 91
Posts 11330
Boards Moderated 0
Alias Born 06/06/2014

Re: growingpain post# 369300

Saturday, 08/06/2022 12:19:32 PM

Saturday, August 06, 2022 12:19:32 PM

Post# of 461439
The Excellence trial was likely expanded for the reason you gave. The Avatar results showed potential signal, but disappointed on dose effect. More patients (and longer time period) clarify signal. (The peds may also have greater 'plasticity'.)

Hopefully we'll be hearing about the FX trial soon, since it is in planning mode according to the current pipeline chart. The company had the time between Avatar results and now to devote resources to it. Not sure how the company can be truly "planning" for the undisclosed indication's trial without having decided what it will be.

On another note, I'm puzzled by the pipeline chart not showing any planned trials yet for 3-71 (no orange).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News